5,272 Shares in Humana Inc. $HUM Acquired by Wealthedge Investment Advisors LLC

Wealthedge Investment Advisors LLC purchased a new position in shares of Humana Inc. (NYSE:HUM) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,272 shares of the insurance provider’s stock, valued at approximately $1,289,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Mackenzie Financial Corp grew its stake in shares of Humana by 27.7% during the second quarter. Mackenzie Financial Corp now owns 30,029 shares of the insurance provider’s stock worth $7,341,000 after purchasing an additional 6,510 shares in the last quarter. Ceredex Value Advisors LLC purchased a new stake in Humana during the 2nd quarter worth about $17,517,000. Norges Bank purchased a new stake in Humana during the 2nd quarter worth about $397,079,000. Crake Asset Management LLP purchased a new position in shares of Humana in the 2nd quarter valued at about $40,816,000. Finally, Quadrature Capital Ltd lifted its stake in Humana by 571.9% during the second quarter. Quadrature Capital Ltd now owns 66,609 shares of the insurance provider’s stock worth $16,283,000 after purchasing an additional 56,695 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on HUM shares. Bank of America increased their price target on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a research note on Friday, October 10th. Sanford C. Bernstein increased their target price on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Barclays cut their price target on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 25th. Truist Financial decreased their price objective on shares of Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research note on Monday, November 10th. Finally, Evercore ISI initiated coverage on Humana in a research report on Monday, September 22nd. They set an “in-line” rating and a $295.00 target price on the stock. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Humana currently has a consensus rating of “Hold” and a consensus target price of $295.94.

Humana Stock Performance

NYSE HUM opened at $245.77 on Monday. The firm has a market cap of $29.56 billion, a P/E ratio of 18.86, a P/E/G ratio of 1.71 and a beta of 0.42. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $315.35. The business’s 50-day moving average price is $263.19 and its 200 day moving average price is $257.04. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the firm earned $4.16 EPS. On average, equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s payout ratio is currently 33.18%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.